Sartorius Stedim Biotech Financial Overview
Sartorius Stedim Biotech's market cap is currently €20.04B. The company's EPS TTM is €0.94; its P/E ratio is 75.92; and it has a dividend yield of 0.31%. Sartorius Stedim Biotech is scheduled to report earnings on October 16, 2025, and the estimated EPS forecast is €1.30. See an overview of income statement, balance sheet, and cash flow financials.
